Sponsor Pipeline

Timothy Pardee Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07471841 Olutasidenib in Relapsed IDH1 Mutated AML Patients Who Have Previously Received Venetoclax IDH1 Mutation Recruiting
Disease Areas
Acute Myeloid Leukemia (AML) (1)
Get alerts when Timothy Pardee's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free